Substituted pyrrolopyridines as jak inhibitors
AssigneeAclaris Therapeutics, Inc.
InventorsEric Jon Jacobsen, David Randolph Anderson, James Robert Blinn, Paramita Mukherjee, Paul Changelian, Canxin Xu
Life of this patent
Estimating the term…
Loading patent…
AssigneeAclaris Therapeutics, Inc.
InventorsEric Jon Jacobsen, David Randolph Anderson, James Robert Blinn, Paramita Mukherjee, Paul Changelian, Canxin Xu
Estimating the term…
The present invention relates to new pyrrolopyridine compounds having the structures of Formula (I)-(IV), wherein the R groups, A, B, C, D and n are as defined in the detailed description, and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibition of JAK kinase activity in a human or animal subject are also provided for the treatment diseases such as pruritus, alopecia, androgenetic alopecia, alopecia areata, vitiligo and psoriasis.
A compound, or a derivative thereof, of Formula (I):
A compound, or a derivative thereof, of Formula (II):
A compound, or a derivative thereof, of Formula (III):
A compound, or a derivative thereof, of Formula (IV):
Dependencies are inferred from the claim text.